L
Lee Edwards
Researcher at GlaxoSmithKline
Publications - 107
Citations - 2064
Lee Edwards is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Epithelial sodium channel & Cystic fibrosis. The author has an hindex of 25, co-authored 102 publications receiving 1673 citations. Previous affiliations of Lee Edwards include University of Manchester & University of Hertfordshire.
Papers
More filters
Journal ArticleDOI
Communication in global crises: critical discourses on consumption, culture, power, and resistance
TL;DR: In this paper , the authors highlight the importance of how global crises get communicated in the market and the associated issues of power dynamics and highlight the disruptive, resistive counter-communications by marginalized and coerced consumers/actors that highlight inequalities and power dynamics produced through such communication.
Patent
Dérivés de la pyrazine en tant que bloqueurs de l'enac
TL;DR: Les compositions de formule (I) et des sels et solvates pharmaceutiquement acceptables desdits composes, ou R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9, and R 10 ont les significations indiquees dans les specifications, sont utiles dans le traitement de maladies associees au blocage du canal sodique epithelial as discussed by the authors.
Patent
Spirocyclic amiloride analogues as ENac blockers
Bhalay Gurdip,Emma Budd,Graham Charles Bloomfield,Collingwood Stephen Paul,Andrew Dunstan,Lee Edwards,Peter Gedeck,Catherine Howsham,Peter Hunt,Thomas Anthony Hunt,Paul Oakley,Nichola Smith +11 more
TL;DR: A compound of Formula I in free or salt or solvate form, where R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 have the meanings as indicated in the specification, is useful for treating diseases which respond to the blockade of the epithelial sodium channel.
Patent
Compositions et procédés pour la modulation de récepteurs au lpa
John Edward Tellew,Xia Wang,Yongqin Wan,Yun Feng Xie,Shifeng Pan,Jiqing Jiang,Yongping Xie,Thomas Anthony Hunt,Lee Edwards,David Beattie,Mark Patrick Healy,Ryan West,Andrew Lister +12 more
TL;DR: In this article, the presente invention porte sur des composes de formule (1), ou des sels pharmaceutiquement acceptables de ceux-ci, and sur leurs compositions pharmacaceutiques, dans laquelle formule les variables sont telles que definies dans the description.